transthyretin amyloidosis with cardiomyopathy

Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
Investors Business Daily
Thu, 10/19/23 - 10:12 am
Intellia
CRISPR
gene editing
transthyretin amyloidosis with cardiomyopathy
Alnylam’s Onpattro succeeds in open-label ATTR cardiomyopathy extension
Clinical Trials Arena
Mon, 05/22/23 - 10:11 am
Alnylam Pharmaceuticals
Onpattro
clinical trials
transthyretin amyloidosis with cardiomyopathy
Alnylam details anticipated results from heart disease drug trial
BioPharma Dive
Thu, 09/8/22 - 10:47 am
Alnylam
clinical trials
Onpattro
transthyretin amyloidosis with cardiomyopathy